{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"24","upperLimit":"37","value":"30"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"64"}],"units":"Participants"}],"description":"defined as time from treatment initiation to death, or last known to be alive for those who had not died","dispersionType":"95% Confidence Interval","groups":[{"id":"OG000","title":"Lenalidomide, Dexamethasone, Bortezomib Combination"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"assesed at a median follow-up of 44 months","title":"Overall Survival","type":"SECONDARY","unitOfMeasure":"month"}